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ABSTRACT 
An ascites  tumor,  Sarcoma  I,  was  transplanted  to isologous and  homologous  mice which 
had been labeled with tritiated thymidine from 1 to 24 hours previously. Radioautographic 
preparations  revealed labeled host lymphocytes emerging to mingle with the transplanted 
tumor  and  the  subsequent  appearance  of nuclear  radioactivity in  the  sarcoma.  Sarcoma 
cells cultured subcutaneously or in Millipore diffusion chambers in previously labeled mice 
did  not  demonstrate  significant  radioactivity.  Transplantation  of washed,  Ha-thymidinc  - 
labeled lymphocytes to non-radioactive, sarcoma-bearing mice was followed by the gradual 
appearance  of nuclear radioactivity in the sarcoma.  The label in the sarcoma was entirely 
removed by deoxyribonuclcase but not by ribonuclease treatment prior to radioautography. 
Intraperitoneal  injections of purified,  Ha-thymidine-labeled sarcoma or lymphoid DNA in 
normal or tumor-bearing mice were followed by radioactivity appearing in sarcoma or nor- 
mal  peritoneal  mononuclear  cells.  It  was  concluded  that  rcutilization  of DNA  and  its 
metabolites may occur in vivo, and the conditions under which reutilization may be detected 
are discussed. 
INTRODUCTION 
Little is known of the fate of deoxyribonucleic acid 
(DNA)  from dying mammalian cells. This is true 
despite  the  importance  of  such  information  for 
genetics  and  also for  the  proper  interpretation  of 
tracer studies of DNA metabolism. 
In  1954 Dancis  and  Balls  (1)  studied  reutiliza- 
tion of nucleic acid metabolites in vivo. Using ani- 
mals labeled with C14-adenine, these workers were 
unable  to demonstrate  reutilization of radioactive 
metabolites by transplanted  tumors,  by parabiotic 
rats, or by the offspring of the labeled animals. The 
belief  that  DNA  and  its  metabolites  were  not 
passed  from one cell to another  was expressed  in 
1959 by Cronkite and coworkers (2).  Subsequently 
Rubini  and  coworkers  (3)  mentioned  the  possi- 
bility of DNA reutilization but felt that  in tracer 
studies  it was  "...  not a  serious problem because 
of great dilution." That DNA and  its metabolites 
are  not  reutilized  at  a  detectable  level has  been 
the  tacit  assumption  in  many  other  excellent 
studies  of DNA synthesis  and  cellular kinetics  in 
various systems (4-7). 
However,  Ottesen  (8)  in  1954  reported  that 
either human  lymphocytes are very long lived or 
that DNA reutilization does occur in this cell series. 
Emphasis  was  subsequently  placed  on  DNA  re- 
utilization within lymphocytic tissues  by  the  bio- 
chemical  studies  of  Hamilton  (9)  and  in  vitro 
morphologic  work  of  Trowell  (10).  The  possi- 
bility of the passage of DNA between lymphocytes 
was suggested again in a  1960 publication of Alpen 
and  coworkers  (1 I).  Perhaps  the most direct evi- 
dence for DNA reutilization in vivo comes from the 
very recent work of Hill and Drfisil (12)  and Hill 
(13).  These  studies  report  that  radioactivity may 
be detected in the DNA of several cell types from 
205 irradiated mice given isologous P~2-1abeled thymo- 
cytes. However, more than half of the radioactivity 
in  the  injected  thymocytes  was  in  acid-soluble 
compounds and not in fully polymerized DNA. It, 
therefore, may be that the label found in the DNA 
of  the  recipient  animal's  cells  originated  from 
compounds other than DNA itself. 
That at least certain cell types have the ability 
to utilize labeled nucleic acids in vitro has been re- 
ported  by  numerous  investigators  (14-17). 
Whether these findings represented incorporation 
of intact nucleic acid or some degradation product 
thereof was not determined. Bensch and King (18) 
have shown that strain L  tissue culture  cells can 
phagocytose  and  utilize  high  molecular  weight 
DNA complexed to protein, but they were unable 
to demonstrate significant uptake of soluble DNA. 
Borenfreund and Bendich (19)  have recently pro- 
duced  convincing evidence for  the incorporation 
of  purified  polymerized  DNA  from  bacteria  or 
human leucocytes into the DNA of growing HeLa 
cells. Similarly, the very recent work of Kay  (20) 
indicates  that  Ehrlich-Littre  ascites  ceils  utilize 
DNA presented to them in vitro. 
The  most interesting question arising from the 
above studies is whether reutilization of DNA or 
its metabolites can  occur  at  a  significant level in 
vivo, and, if so, what is the sort and size of molecule 
transferred.  To  answer this question experiments 
were  performed  in  which  DNA-synthesizing 
tissues were grown in vivo in the presence of DNA 
previously  tagged  with  radioactive  thymidine. 
MATERIALS  AND  METHODS 
Three  general  classes  of  experiments  utilizing  an 
ascites tumor,  Sarcoma I,  and adult  mice of eithcr 
sex from the  Ajax or  C~TBI strain  were performed. 
The  sarcoma was  isologous to  the Ajax strain  and 
was supplied to this laboratory through the generosity 
of Professor R. Weiser, Department of Microbiology, 
University of Washington, Seattle. 
1.  Transplantation  of Sarcoma  Cells to Hosts 
Previously  Labeled with H~-Thymidine 
Twelve  mice  (six  from  each  strain)  received  a 
subcutaneous or intrapcritoncal injection of 1 to  1.5 
#c/gm  body  weight  tritiated  thymidine  (TTH, 
Schwarz  Laboratories,  Mt.  Vernon,  New  York, 
specific activity cither 0.36  or  1.9  C/EM).  Of these 
animals, four groups of two received intraperitoncal 
injections of 0.3  cc  ascites sarcoma fluid  (approxi- 
mately  1.5  X  l0  T cells to each animal)  at  l,  4,  18, 
or 24 hours after isotope administration. Smears were 
made  of  the  sarcoma  fluid  at  the  time  of  trans- 
plantation  and  of peritoneal  aspirates  drawn  from 
recipient animals at intervals of 1 to 54  hours after 
tumor  introduction.  Control  smears  corresponding 
in  intervals  to  the  experimental series  were  taken 
from an animal which received an injection of saline 
instead  of isotope  18  hours  before  sarcoma  trans- 
plantation. 
One  of the  initial  twelve  labeled mice  received 
0.05  cc sarcoma fluid subcutaneously 3  hours  after 
isotope  administration.  The  tumor  was  allowed  to 
grow for 24  hours before it was excised and teased 
for smear preparations. 
Each  of  the  final  three  mice  had  a  Millipore 
diffusion chamber  (21)  containing 0.15  cc sarcoma 
fluid  implanted  in  its  peritoneal  cavity  12  hours 
after isotope injection. These animals were sacrificed 
at  12,  24,  and 48  hours after chamber implantation 
so that smears of chamber contents and of the inner 
surfaces of the diffusion membranes could be made. 
Control  and experimental smears were processed 
together  for  radioautography  utilizing  the  liquid 
emulsion technique (21,  22).  The coated slides were 
exposed  2  to  5  weeks  and,  after  developing  and 
drying, were stained  15  to  30  minutes at  5°C  in  1 
per cent Leishmann-Giemsa (1:3)  pH 6.7.  Finished 
radioautographs were evaluated microscopically and 
in some instances subjected to grain counts.  Counts 
were accomplished by enumerating silver grains over 
one  to  two  hundred  sarcoma  cells  and  then  sub- 
tracting the number of background grains found in 
areas  adjacent to  and  approximately the same size 
as  the  areas  of  the  cells  counted.  The  difference 
figure thus obtained was divided by the number of 
cells  counted  to  yield  an  estimate  of  average  net 
grains per cell (Fig.  5).  Before counting the prepara- 
tions, they were coded and mixed so that the author 
was unaware of whether an experimental or control 
smear was to be examined. 
~.  Transplantation  of H3- Thymidine-Labeled 
Lymphocytes  to  Sarcoma-Bearing  Mice 
One  Ajax  and  one  C~TB1 mouse  received  daily 
injections  of  0.5  to  1  #c/gm  body  weight  TTH 
amounting in  total  to  76  and  100  /zc  respectively. 
Two hours after their last injection they were sacri- 
ficed and cell suspensions were prepared by mincing 
the  pooled  spleen,  thymus,  and  mesenteric lymph 
nodes of each animal. The cells were twice washed in 
cold Ringer's solution  and  then  were suspended in 
homologous  serum  for  injection  directly  into  the 
ascites  fluid  of  non-radioactlve,  sarcoma-bearing 
Ajax  mice.  One  mouse  received  9.3  X  l0  T and 
another received 1.6  X  l0  s nucleated cells.  Smears 
were made of the transplanted lymphoid cells and of 
fluid  obtained  by  peritoneal  paracentesis from  the 
recipient animals at  l,  3,  5,  7,  9,  1  l,  and 24  hours 
after lymphocyte transplantation. These smears were 
206  THE  JOURNAL OF  CELL  BIOLOGY •  VOLUME 13,  1962 processed for radioautography as  above except that 
two smears of each interval were saved for specific 
nuclease treatment prior to liquid emulsion coating. 
One smear of each interval was digested for  1 hour 
at 37°C with ribonuclease (Mann Research Labora- 
tories, New York) in a concentration of 0.5 mg/cc in 
phosphate  buffer  pH  6.7.  Another  smear  of  each 
interval was treated for 1 hour at 37°C with deoxy- 
ribonuclease (Worthington Biochemical Corporation, 
Freehold,  New  Jersey)  in  a  concentration  of  0.5 
rag/co in phosphate buffer pH  6.7  which was  10  .3 
M in  Mg  ++.  After enzyme digestion, the slides were 
washed  in  distilled  water,  dried,  and  radioauto- 
graphed with untreated slides. 
3.  Injection  of  H3-Thymidine-Labeled  Sar- 
coma  or  Lymphoid  DNA  into  Tumor- 
Bearing  and Normal Mice 
The  biochemical  methods  of  Kirby  (23)  were 
employed to  isolate  radioactive  sarcoma  and  lym- 
phoid DNA from tumor-bearing and normal TTH- 
injected mice.  For  this  purpose  a  sarcoma-bearing 
mouse  received  two  intraperitoneal  injections 
totaling 4.0  pc TTH,  and a  normal mouse similarly 
received two injections totalling 33 pc. After isolation 
of the DNA from the sarcoma, or from the pooled 
spleen, thymus, and mesenteric lymph nodes of the 
normal animal, the DNA was freed of RNA by ribo- 
nucleasc  digestion  (1  hour  at  35°C  in  phosphate 
buffer pH 6.7  with RNase in  final concentration of 
0.3  mg/cc).  Colorimctric assays  (24,  25)  were then 
employed to  determine DNA  content and  confirm 
the absence of RNA.  Half of each DNA sample was 
treated  with  deoxyribonuclcase  (conditions  as 
described) until  colorimetric assays showed that  at 
least 95  per cent of the original polymerizcd DNA 
had been degraded. For injection the DNA and the 
DNase-digcsted  samples  were  suspended  in  saline 
and made  10  -3 M in  Mg  ++.  Approximations of the 
amount  of radioactivity in  the purified DNA  were 
made  by  assaying,  l,  5,  and  l0  #g  aliquots  in  a 
windowless, gas-flow counter.  The  specific  activity 
of the sarcoma  DNA  was  found  to  be  about  sixty 
times greater than that of the lymphoid DNA. 
Incorporation of the sarcoma DNA preparations 
was  tested  by  making  intraperitoneal  injections of 
100/~g  of the purified DNA or an equivalent amount 
of the DNase-digestcd material twice daily in normal 
and  tumor-bearing Ajax mice.  Similarly,  injections 
of 50  #g  amounts  of lymphoid DNA  and  digested 
DNA  were  made  in  normal  and  tumor-bearing 
animals.  Smears  of peritoneal  aspirates were made 
for  radioautography  at  daily  intervals  from  all 
animals after the beginning of the injections. 
RESULTS  AND  DISCUSSION 
Appearance  of  Radioactivity  in  Sarcoma  I 
Transplanted  to  Hosts  Previously  Labeled 
with H 3- Thymidine 
Figs.  1 to 4  depict the temporal appearance of 
nuclear radioactivity in sarcoma cells cultured in 
a  mouse which was injected with TTH  18  hours 
before  tumor  transplantation.  It  is  to  be  noted 
that labeled host lymphoid cells emerged to mingle 
with the tumor cells (Fig. 2) and that their appear- 
ance was followed by the gradual development of 
radioactivity  in  the  sarcoma.  Fig.  5  expresses 
graphically the rate, degree, and duration of label- 
ing of tumor cells in this same experimental animal 
compared  to  a  saline-injected control.  The  slope 
and area under the curve in Fig.  5 were found to 
be a  function of the interval which separated the 
injection of the host with isotope and  the  trans- 
plantation of the sarcoma. Short intervals of 1 to 2 
hours produced maximally steep slopes and large 
areas under the curve. Twenty-four hour intervals 
flattened the curve and shifted it to the right. The 
curve did not seem to be influenced by either the 
specific activity or  the route  of administration of 
the isotope. 
In  the  most  general  sense,  the  appearance  of 
radioactivity localized  discretely in  the  nuclei  of 
sarcoma cells was  taken  to  mean  that  either  the 
sarcoma  had  used  host  radioactive  materials  in 
synthesizing DNA or that previously labeled host 
cells had transformed to sarcoma cells. A  selection 
between  these  alternatives was  suggested  by  the 
marked difference in silver grain density in radio- 
autographs  of tumor  cells  compared  to  lympho- 
cytes. In no case was a sarcoma cell observed with 
a  grain  density  even  approaching  that  which 
would  have  been  expected  if  it  had  arisen  by 
transformation  of  the  usual  well  labeled  host 
lymphocyte. That  transformation was  not occur- 
ring was further argued by other experiments (26) 
which demonstrated that the percentage of directly 
labeled  sarcoma  ceils  cultured  in  a  non-labeled 
host did not decline in the first 48 hours.  Such a 
decrease would have been expected if non-labeled 
host cells were transforming to sarcoma cells. 
The  evidence  that  the  sarcoma  was  utilizing 
labeled  host  materials  in  synthesizing  its  DNA 
raised  the  question  of  the  source  of  these  sub- 
stances.  It did  not seem that  persistent unbound 
host  TTH  could  have  caused  the  labeling,  for 
tumor  transplantation was  not  undertaken  until 
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FIGURE 5 
Appearance  of  radioactivity  in  Sarcoma  I  cells 
transplanted to  a  previously  labeled  mouse  com- 
pared  to  sarcoma  cells  transplanted  to  a  control 
animal.  The  experimental  animal  was  injected 
with 1 #c/gin H3-thymidine 18 hours before tumor 
introduction  while  the  control  received  saline 
rather  than  isotope.  See  text  (Materials  and 
Methods)  for  description  of  grain  counts  repre- 
sented here. The fact that the control curve remains 
negative rather than zero is a  reflection of the fact 
that background reduction  in  radioautography is 
usually  greater in  areas  where  there  are  no  cells 
than in areas directly over cells. 
the availability time of TTH  in the host had been 
exceeded by ~  to 24 hours (2, 3). The gradual in- 
crease in radioactivity in the sarcoma (Fig. 5)  also 
argued  against  prolonged  availability  of  TTH 
unless it were slowly being released from some un- 
known body  pool.  Furthermore,  neither a  subcu- 
taneously  implanted  sarcoma  (Fig.  6)  nor  one 
grown  intraperitoneally  in  a  Millipore  diffusion 
chamber (Fig.  7)  took up significant radioactivity 
from a  previously labeled host.  Tumors grown in 
these sites provided strongest evidence that neither 
persistent TTH  nor, indeed, any freely circulating 
metabolite  of it was  the  labeling  substance.  The 
capability of these latter tumors to utilize a  circu- 
lating  metabolite  if it  had  been  present  seemed 
certain.  The  subcutaneous  tumor  grew  rapidly, 
and  intraperitoneal  chamber  tumors  were  easily 
labeled  by TTH  given intravenously as  much  as 
40 hours after chamber implantation  (Fig.  8). 
As  noted  above,  radioactivity  was  detected  in 
sarcoma  cells  growing  freely  in  the  peritoneal 
cavity only  after labeled  host lymphoid  cells had 
appeared  and  mixed  with  the  tumor.  Significant 
radioactivity  was  not  found  in  a  subcutaneous 
tumor but neither were any number of labeled host 
cells found.  Similarly, label of any extent was not 
found  in  diffusion  chamber  sarcoma  cells  which 
were  prevented from  contacting  radioactive  host 
cells  by  the  presence  of the  diffusion membrane. 
These  findings  strongly  suggested  that  the  sub- 
stance  effecting  the  labeling  in  the  sarcoma  was 
lymphocyte bound. 
FIGURE  1 
Radioautographic  preparation  of Sarcoma  I  cells  1  hour  after  transplantation to  a 
mousc which had bccn injected with H&thymidine 18 hours before tumor introduction. 
The sarcoma contains no radioactivity although it is growing well  (note metaphasc). 
X  1440. 
FIGURE 
Radioautograph of Sarcoma I  cells from the same experiment as Fig.  l, now 3 hours 
after  transplantation.  The  sarcoma  still  has  no  detectable  radioactivity  but  a  host 
lymphocyte which has emerged is well labeled.  Note unlabeled pyknotic host cell at 
upper left.  X  1440. 
FIGURE 3 
Radioautograph of Sarcoma I  cells from the same experimcnt as  Figs.  1 and 2,  but 
now  12  hours  aftcr  transplantation.  Note  definite nuclear label  on  several sarcoma 
cells including the anaphase figure at upper left.  X  1440. 
FIGURE 4 
Radioautograph of Sarcoma I  cells from the same experiment as above, now 24 hours 
after transplantation. Many sarcoma cells now show distinct nuclear lable.  X  1440. 
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which Received Transplanted H3-Thymidine- 
Labeled Lymphocytes 
Transplantation  of  washed  pooled  thymus, 
spleen,  and  mesenteric  node  lymphocytes  was 
undertaken  from  either  isologous  or  homologous 
TTH-labeled  donors  to  non-labeled,  sarcoma- 
bearing recipients. These experiments proved to be 
critical in the demonstration of the cell-fixed char- 
acter  of  the  substance  causing  sarcoma  labeling. 
The results  (Figs.  9  to  11)  were strikingly similar 
to those obtained with transplantation of sarcoma 
cells to  previously labeled hosts  (Figs.  1 to 4).  In 
all  cases  the  sarcoma  gradually  became  radioac- 
tive.  Specific  nuclease  treatment  of  the  sarcoma 
was then employed to demonstrate that the label- 
ing  truly  represented  incorporation  of  material 
from  lymphocytes  into  sarcoma  DNA.  Ribonu- 
clease  digestion  did  not  remove  the  label  in  the 
tumor cells (Fig.  12), but deoxyribonuclease treat- 
ment  did  (Fig.  t3).  Lymphocytes  undergoing 
pyknosis  and  karyorrhexis  were  frequently  ob- 
served  in  these  experiments  as  well  as  in  those 
involving transplantation of the sarcoma  to previ- 
ously  labeled  hosts.  The  evidence  of  lymphocy- 
tolysis  suggested  that  released  radioactive  DNA 
was  the  cell-fixed  product  responsible  for  the 
labeling  observed  on  the  sarcoma.  Accordingly 
the capacity of biochemically purified, radioactive 
DNA  to  label  DNA-synthesizing  cells  was  in- 
vestigated. 
Appearance  of Radioactivity  in  Normal  and 
Malignant  Cells after Injections of H 3- Thymi- 
dine-Labeled DNA 
When  biosynthetically  labeled,  purified,  lym- 
phoid  DNA  was  injected  into  non-radioactive, 
sarcoma-bearing  mice,  the  tumor  cells  incorpo- 
FIGURE 6 
Radioautographic  preparation  of Sarcoma  I  cells  transplanted subcutaneously  to  a 
mouse which had been injected with H3-thymidine 3 hours previously. This preparation 
was made after the sarcoma had grown for 24 hours and it may be seen that the cells 
do not contain radioactivity.  X  1200. 
I~IGURE  7 
Radioautographie  preparation  of Sarcoma  I  cells cultured  24  hours  in  a  Millipore 
diffusion chamber which was implanted intraperitoneally 12 hours after the host was 
labeled with H3-thymidine.  The cells grew well,  but did not become radioactive.  X 
1200. 
FIGURE 8 
Radioautograph of Sarcoma I  cells cultured 40 hours in an intraperitoneal Millipore 
diffusion chamber. To test the viability of these cells, the host mouse was labeled for 
the  first  time  by  the  intravenous injection of H3-thymidine  30  minutes  before  this 
preparation was made. The incorporation of thymidine is marked.  X  1440. 
FIGURE  9 
Radioautograph  of  Sarcoma  I  cells  from  a  non-radioactive,  tumor-bearing  mouse 
which 1 hour previously had been injected with washed, H3-thymidine-tagged lympho- 
cytes. Note labeled lymphocytes, but absence of radioactivity on the sarcoma.  X  1440. 
FIGURE  10 
Radioautograph of Sarcoma I  cells from the same experiment as Fig.  9, now 5  hours 
after lymphocyte introduction. Note the labeled transplanted lymphocyte (upper right) 
and the beginning appearance of radioactivity in the sarcoma.  X  1440. 
FIGURE  11 
Radioautograph of Sarcoma I cells from the same experiment as in Figs. 9 and 10, but 
now 24  hours  after radioactive lymphocyte  transplantation.  Sarcoma  cells now fre- 
quently show distinct nuclear label.  X  1440. 
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results were  obtained with labeled sarcoma DNA 
presented  to sarcoma cells  (Fig.  15).  The appear- 
ance  time,  degree,  and  duration  of  radioactivity 
in  these  sarcoma  cells  was  very  similar  to  that 
observed  in  the earlier experiments  (Fig.  5). 
Whether  normal  as  well  as  neoplastic  cells 
would utilize DNA was then studied in peritoneal 
mononuclear  ceils  recovered  from  normal  mice 
which  had  received  radioactive  DNA  intraperi- 
toneally.  TTH-labeled,  isologous lymphoid  DNA 
caused radioactivity to appear in several cell types, 
particularly in cells resembling large undifferenti- 
ated blasts and in lymphocytes (Fig.  16).  Labeled 
sarcoma DNA  also was  utilized  by many  normal 
cells,  but  apparently  especially  by  macrophages 
(Fig.  17). Approximately 1 per cent of the lympho- 
cytes  and  macrophages  were  labeled  by  the  in- 
jeered DNA,  but the differing specific activities of 
the lymphoid and sarcoma DNA made it impossi- 
ble to compare the degree of uptake of each.  The 
demonstration of incorporation  of injected  DNA 
is  in  good  correlation  with  the  earlier  studies  of 
Hudnik-Plevnik and coworkers  (27)  who followed 
the fate of P3Mabeled spleen DNA  injected intra- 
peritoneally. 
A  striking observation worthy  of emphasis was 
that polymerized DNA from any source was much 
more  effective  in  labeling  normal  or  neoplastic 
cells than was a DNase digest with the same radio- 
active and nucleotide content.  Intact DNA mole- 
cules  labeled  more  cells  and  labeled  them  more 
heavily than did the same quantity of DNA which 
had  been  hydrolyzed  by  specific  nuclease  treat- 
ment. 
The  presentation  of equal  quantities  of  radio- 
FIGURE  12 
Radioautograph of Sarcoma I  cells from the same experiment and interval as Fig.  11, 
but  digested  with  ribonuclcasc  before  radioautographic  processing.  Note  from  the 
cell in the upper right that RNasc did not remove the nuclear label.  X  1440. 
I~GURE  13 
Radioautographic  preparation  of  Sarcoma  I  cells  from  the  same  experiment  and 
interval  as  Fig.  II,  but  digested  with  dcoxyribonuclease  before  radioautographic 
processing. Note that nuclear radioactivity is entirely removed.  X  1440. 
FIGURE  14 
Radioautograph of Sarcoma I  cells from a  mouse which had been injected with H 3- 
thymidine-tagged  isologous  lymphoid  DNA  22  hours  previously.  Note  uptake  of 
radioactive DNA into the nucleus of the sarcoma cell in the center.  X  1440. 
FIGURE  15 
Radioautograph of Sarcoma I  cells from a  mouse which had been injected with H 3- 
thymidinc-tagged sarcoma DNA 4  hours previously. Note uptake of radioactive DNA 
into the nuclei of the tumor cells.  X  1440. 
FIGURE 16 
Radioautograph of a  peritoneal mononuclear cell (right) and lymphocyte (left)  taken 
from  thc  peritoneal  cavity  of  a  normal  mouse  which  had  been  injected  with  H 3- 
thymidine-tagged,  isologous  lymphoid  DNA  24  hours  previously.  Note  uptake  of 
radioactive I)NA into the nuclei of these cells taken from different fields on the  same 
slide.  X  1440. 
FIGURE  17 
Radioautograph  of peritoneal macrophages  taken from  a  normal  mouse which  had 
been  injected  with  H3-thymidine-tagged  sarcoma  DNA  67  hours  previously.  Note 
uptake of radioactive DNA into the nucleus of the cell on the right.  X  1440. 
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vided  direct  evidence  that  labeled  cells  resulted 
from actual incorporation of labeled materials and 
not  from  exchange  of  tritium  atoms  between 
labeled  and  unlabeled  molecules. The stability of 
tritium on  thymidine  in DNA has  not  been  seri- 
ously challenged,  but has  been little more than  a 
well based  assumption  (2). 
Conditions  and  Significance  of  Reutilization 
of DNA  and Its Metabolites 
The  observations  above  left  little  doubt  that 
both  neoplastic  and  normal  cells were capable  of 
significant  reutilization  of DNA  and  its  metabo- 
lites. Relatively precise identification of the condi- 
tions  under  which  reutilization  occurred  seemed, 
then,  of  obvious  importance.  Accordingly,  the 
following four characteristics  of reutilization were 
developed from  the experimental  data. 
In  the  first  place,  reutilization  was  noted  only 
when labeled host cells (mainly lymphocytes)  had 
direct  access  to  unlabeled  (sarcoma)  cells.  Only 
after  direct  cellular  interplay  was  extensive 
lymphocytolysis  with  release  and  subsequent  in- 
corporation  of  labeled  DNA  observed.  The  in- 
corporation  of  the  released  DNA  probably  was 
achieved  by  pinocytosis.  Incorporation  did  not 
seem  to  occur  by  phagocytosis  as  reported  in 
lymphoid reticulum  cells by Trowell  (10)  and  in 
strain L  cells by Bensch and King (18), for phago- 
cytosis  of intact  cells or  gross  amounts  of DNA 
was  only very rarely  observed.  Furthermore,  the 
minimal labeling observed in sarcoma cells grow- 
ing  among  very  heavily  labeled  lymphocytes 
argued  against frequent phagocytosis of large bits 
of radioactive debris.  Why  lymphocytes  were  in- 
duced  to  die  and  release  their  nucleoproteins  so 
soon  after  transplantation  of an  isologous  tumor 
was unclear.  Medawar  (28),  of course,  has  postu- 
lated  that lymphocytes may function as vectors of 
nucleic acids. 
In the second place, only cells which were actu- 
ally synthesizing DNA incorporated  labeled DNA 
or its metabolites.  All of the cell types labeled  by 
reutilization  in  this  study  (viz. sarcoma  cells, 
macrophages,  large  mononuclear  cells,  and  lym- 
phocytes)  were  known  to  be  capable  of  DNA 
synthesis  as  judged  by  the  ability  to  use  TTH 
(21,  26).  Hill and  Dr~sil  (12),  however,  reported 
finding  labeled  mature  neutrophils  in  lethally ir- 
radiated mice injected with P32-tagged thymocytes. 
The  neutrophil  in  their  study  probably  was  not 
capable of DNA synthesis, which does not occur in 
this  cell  series  after  the  last  myelocyte  division 
(2, 29).  It may be that labeled nuclear debris from 
injected thymocytes was incorporated just prior to 
this division, but the fact that  at least some of the 
label was cytoplasmic instead  of nuclear makes it 
more  probable  that  incorporation  was  by  phago- 
cytosis.  The  phagocytic  properties  of neutrophils 
are  well known,  and  the  radiation  given the  re- 
cipient  animals  possibly  enhanced  this  process. 
Thirdly,  reutilization of labeled DNA materials 
was  most  easily  detected  when  short  intervals 
separated  the  injection  of  an  animal  with  TTH 
and  the  introduction  of  an  unlabeled,  DNA- 
synthesizing  tissue.  Although  it  was  clear  that 
radioactive,  polymerized  DNA  was  reutilized  in 
some  of the  above  experiments,  it  was  probable 
that  labeled DNA precursors  were also reutilized. 
When  the  sarcoma  was  transplanted  to  hosts 
which  had  been  labeled  only  a  few  hours  previ- 
ously,  a  high  percentage  of labeled  lymphocytes 
emerged to meet the sarcoma.  These lymphocytes 
probably contained large amounts of labeled DNA 
precursor  substances  (anabolites).  Indeed,  Cra- 
thorn  and  Shooter  (30)  have  shown  that  1 hour 
after  the  presentation  of  TTH  to  (ascites)  cells 
in vitro the majority of cell-fixed radioactivity is not 
in  DNA,  but  is  in  DNA precursors  (mono-,  di-, 
and  triphosphonucleotides).  The  release  of such 
anabolites by lysis of recently labeled lymphocytes 
probably  provided  a  readily  available  pool  of 
radioactive DNA precursors. 
In  the  fourth  place,  reutilization  was  best 
demonstrated  when  it  was  the  consequence  of 
acutely  increased  metabolic demand  placed  on  a 
labeled  host.  For example,  transplantation  of the 
usual  inoculum  of  tumor  cells  (1.5  X  10 v)  in- 
creased  the  number of cells to be supported  by a 
20  grn mouse  in  a  manner  roughly  equivalent to 
adding abruptly  7 per cent to the total number of 
bone  marrow  cells synthesizing  DNA  (31).  That 
the effect of transplanting  the sarcoma was meta- 
bolic rather  than  "toxic" was concluded from the 
observation  of  nearly  equivalent  reutilization  of 
DNA by tumors transplanted  to either isologous or 
homologous hosts.  In fact,  even in previously im- 
munized,  homologous  hosts,  the  sarcoma  in- 
corporated radioactivity as long as it lived. 
The data suggested that the molecules reutilized 
under  the  conditions  above  included  both  DNA 
and  its  metabolites.  Probably  the  degree  of  in- 
corporation of each was dependent on the type of 
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labeled materials were presented.  Evidence for the 
uptake  of  anabolic  DNA  substances  has  been 
cited  above,  and  that  catabolites  similarly  were 
available  was  considered  probable  from  reports 
that ascites ceils contain DNase (32)  and release at 
least  certain  of  their  enzymes  into  their  growth 
medium  (33). 
The evidence for incorporation  of relatively in 
tact DNA derived from the observation that poly- 
merized,  radioactive  DNA effected  greater  label- 
ing  than  did  equal  quantities  of DNase-digested 
material.  The  indication  that  intact  DNA  was 
incorporated  in some experiments  gained support 
from the studies of Borenfreund  and  Bendich  (19) 
who  employed  an  antibody  against  DNase  to 
demonstrate  the  incorporation  of  polymerized 
DNA by HeLa cells in vitro. Kay (20) has reported 
that once DNA is incorporated  it may be utilized 
without  intracellular  degradation.  If large  mole- 
cules were incorporated and utilized intact in some 
of the  above  experiments,  genetic  change  should 
eventually be detectable.  Such a  change has been 
reported  by  Kurita  and  coworkers  (34)  who 
transferred  alanine-nitrogen  mustard  resistance  to 
Yoshida  sarcoma  cells  in  a  DNase,  gene-specific 
reaction.  Furthermore,  the  very recent  studies  of 
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